CVS Health Corp (CVS)
68.49
+0.35 (0.51%)
NYSE · Last Trade: Jun 27th, 5:20 PM EDT
The case stems from a whistleblower lawsuit filed by a former Aetna actuary who alleged CVS Caremark manipulated drug pricing to inflate Medicare claims while underpaying pharmacies.
Via Stocktwits · June 26, 2025
Shares of CVS Health are trading higher Thursday afternoon. The stock is climbing after a GOP healthcare bill hit a roadblock in the Senate.
Via Benzinga · June 26, 2025
The provisions at risk include the plan to hold down Medicaid costs by cracking down on a state provider tax.
Via Stocktwits · June 26, 2025
Each stock in this article is trading near its 52-week high.
These elevated prices usually indicate some degree of investor confidence, business improvements, or favorable market conditions.
Via StockStory · June 26, 2025
Several major U.S. health insurers announce they will voluntarily speed up and simplify the prior authorization process.
Via Benzinga · June 23, 2025
Donald Trump Jr. has joined Mark Cuban in publicly voicing disapproval of Sen. Elizabeth Warren's approach to healthcare pricing.
Via Benzinga · June 21, 2025
Via Benzinga · June 20, 2025
A debate over the healthcare system erupted on X, pitting Mark Cuban against Elizabeth Warren over the root causes of soaring drug prices.
Via Benzinga · June 20, 2025
The research firm expects lower enrollment growth as UnitedHealth exits unprofitable plans and prioritizes margin discipline.
Via Stocktwits · June 19, 2025
The draft Senate bill introduces stricter work requirements and funding curbs for Medicaid, while shelving proposed Medicare cuts that could have impacted major insurers.
Via Stocktwits · June 16, 2025
Several major large-cap stocks, each with a market capitalization of over $30 billion, have recently announced notable increases to their quarterly dividends. These updates, aligned with recent shareholder meetings and strategic decisions, reflect efforts to enhance shareholder value and demonstrate financial strength.
Via MarketBeat · June 16, 2025
Via The Motley Fool · June 14, 2025

Humana is joining lawmakers in support of limiting Medicare Advantage payments tied to home visit diagnoses.
Via Benzinga · June 5, 2025

Nearly 80% of S&P 500 firms beat Q1 earnings forecasts. Profit growth hit 13.3%, led by tech and health care, says FactSet.
Via Benzinga · June 3, 2025

Amazon Pharmacy introduces caregiver support and expands PillPack access for Medicare users, simplifying medication routines with secure tools and pre-sorted packets.
Via Benzinga · June 3, 2025

Stay updated with the movements of the S&P500 index one hour before the close of the markets on Friday. Discover which stocks are leading as top gainers and losers in today's session.
Via Chartmill · May 30, 2025

Large-cap stocks are known for their staying power and ability to weather market storms better than smaller competitors.
However, their sheer size makes it more challenging to maintain high growth rates as they’ve already captured significant portions of their markets.
Via StockStory · May 30, 2025

Eli Lilly is rapidly encroaching on Novo Nordisk's yearslong lead in GLP-1 drugs. Can Novo hold its tentpole position?
Via Investor's Business Daily · May 29, 2025

Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at Humana (NYSE:HUM) and the best and worst performers in the health insurance providers industry.
Via StockStory · May 28, 2025

Get insights into the S&P500 index performance on Wednesday. Explore the top gainers and losers within the S&P500 index in today's session.
Via Chartmill · May 28, 2025

Curious about the S&P500 stocks that are in motion on Wednesday? Join us as we explore the top movers within the S&P500 index during today's session.
Via Chartmill · May 28, 2025